Xenon Pharmaceuticals, Inc. (XENE)
43.66
+0.22
(+0.51%)
USD |
NASDAQ |
Dec 11, 16:00
43.61
-0.05
(-0.11%)
After-Hours: 20:00
Xenon Pharmaceuticals Cash from Investing (Quarterly): 38.76M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0051M |
| Aurinia Pharmaceuticals, Inc. | -14.04M |
| Edesa Biotech, Inc. | 0.00 |
| Lexaria Bioscience Corp. | -0.1579M |
| ProMIS Neurosciences, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -72.46M |
| Cash from Financing (Quarterly) | 2.392M |
| Free Cash Flow | -253.05M |
| Free Cash Flow Per Share (Quarterly) | -0.918 |
| Free Cash Flow to Equity (Quarterly) | -72.36M |
| Free Cash Flow to Firm (Quarterly) | -72.75M |
| Free Cash Flow Yield | -7.35% |